Mayte Pérez‐Olmeda

Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study

Marina Pollán, Beatriz Pérez‐Gómez, Roberto Pastor‐Barriuso et al. · The Lancet · 2020 · 1.9K citations · Full text

Virus Epidemiology, Covid-19 Pandemic, Disease Surveillance +6

Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

Alberto M. Borobia, Antonio J. Carcas, Mayte Pérez‐Olmeda et al. · The Lancet · 2021 · 384 citations · Full text

Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain

M Gómez-Cano, Amalia Rubio, Teresa Puig et al. · AIDS · 1998 · 299 citations

Drug Resistance Analysis, Antiretroviral-experienced Hiv-infected Patients, Codon 215 +13

Pegylated IFN-α2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients

Mayte Pérez‐Olmeda, Marina Núñez, Míriam Romero et al. · AIDS · 2003 · 200 citations

Infection fatality risk for SARS-CoV-2 in community dwelling population of Spain: nationwide seroepidemiological study

Roberto Pastor‐Barriuso, Beatriz Pérez‐Gómez, Miguel A. Hernán et al. · BMJ · 2020 · 189 citations · Full text